AI-generated summary
The authors analyzed myopic children receiving repeated low-level red light therapy from two randomized trials, defining full myopia control as axial elongation under 0.1 mm per year. Early changes in axial length over three months were the strongest predictor of outcome at one and two years, with changes in choroidal thickness contributing less, though the prediction for two-year control from choroidal change was weaker.
- Participants
- 148
- Studies included
- 2
- Who or what was studied
- Myopic children undergoing repeated low-level red light therapy in a multi-center randomized trial (training set) and a single-center randomized trial (validation set)
- Limits stated in the abstract
- The abstract does not state the wavelength used and reports a retrospective analysis of data from trials rather than a prospective prediction study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Myopia, Repeated low-level red light, Red light therapy, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.